Addressing the Importance of Understanding the Subtypes of Thyroid Cancer
Andrew Turk, MD, discusses the importance of discussing thyroid cancer at major meetings, such as the 2019 ASCO Annual Meeting. It is important for physicians to keep up to date on the latest advancements for treatment options and new understandings of the disease and its subtypes.
Andrew Turk, MD, assistant professor of pathology and cell biology, Columbia University, discusses the importance of discussing thyroid cancer at major meetings, such as the 2019 ASCO Annual Meeting. It is important for physicians to keep up to date on the latest advancements for treatment options and new understandings of the disease and its subtypes.
Thyroid cancer is not only extremely common, but it is also 1 of the most common forms of cancer, says Turk. In recent years, a number of advancements have been made in the field of thyroid cancer and understanding the disease. For example, new diagnostic categories have emerged; oncologists and pathologists need to be away of these categories in order to make individual treatment decisions for each patient with thyroid cancer.
Anticipating Novel Options for the RAI-Refractory DTC Armamentarium
May 15th 2023In season 4, episode 6 of Targeted Talks, Warren Swegal, MD, takes a multidisciplinary look at the RAI-refractory differentiated thyroid cancer treatment landscape, including the research behind 2 promising systemic therapy options.
Listen
